Evidence map›Paper›PMID 23662108›Full record

ArticlePersonalized medicine2012

After the revolution? Ethical and social challenges in 'personalized genomic medicine'

Eric T Juengst, Richard A Settersten, Jennifer R Fishman, Michelle L McGowan

Abstract read
In one paragraph

Article in Personalized medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Team Learning for Healthcare Quality Improvement.IEEE access : practical innovations, open solutions · 2013
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eric T JuengstUniversity of North Carolina - Chapel Hill, Center for Bioethics, 333 MacNider Hall, Chapel Hill, NC 27599-7240, USA.
Richard A Settersten
Jennifer R Fishman
Michelle L McGowan

Funding

Supplement to Anticipating Personalized Genomic Medicine: Impact and ImplicationsR01HG005277 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FISHMAN, JENNIFER, JUENGST, ERIC T · 2010 to 2013
$2.3M
NHGRI NIH HHS R01 HG005277
6 · The paper itself

Abstract

Personalized genomic medicine (PGM) is a goal that currently unites a wide array of biomedical initiatives, and is promoted as a 'new paradigm for healthcare' by its champions. Its promissory virtues include individualized diagnosis and risk prediction, more effective prevention and health promotion, and patient empowerment. Beyond overcoming scientific and technological hurdles to realizing PGM, proponents may interpret and rank these promises differently, which carries ethical and social implications for the realization of PGM as an approach to healthcare. We examine competing visions of PGM's virtues and the directions in which they could take the field, in order to anticipate policy choices that may lie ahead for researchers, healthcare providers and the public.

Indexed as

empowermentparticipatorypersonalizationpredictionpreventionsocial worldsstakeholders

Identifiers

PMID23662108
PMCPMC3646379

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.